Lilly to Acquire Akouos to Discover and Develop Treatments for Hearing Loss
Provided By PR Newswire
Last update: Oct 18, 2022
Proposed acquisition will accelerate gene therapies that aim to restore, improve, and preserve hearing for patients living with disabling hearing loss worldwide
Read more at prnewswire.comNYSE:LLY (7/29/2025, 10:42:09 AM)
775.565
-32.54 (-4.03%)
Find more stocks in the Stock Screener
LLY Latest News and Analysis
